Literature DB >> 25031706

Establishment and characterization of a new highly metastatic human osteosarcoma cell line derived from Saos2.

Lin Du1, Qiming Fan2, Bing Tu2, Wei Yan2, Tingting Tang2.   

Abstract

Osteosarcoma is the most common primary malignancy of bone in adolescents and young adults. There is a shortage of tumorigenic and highly metastatic human osteosarcoma cell lines that can be used for metastasis study. Here we establish and characterize a highly metastatic human osteosarcoma cell line that is derived from Saos2 cell line based on bioluminescence. The occasional pulmonary metastatic cells developed from Saos2 were isolated, harvested, characterized and named Saos2-l. The parental Saos2 and Saos2-l cells were further characterized both in vitro and in vivo. Results showed that Saos2-l cells demonstrated increased cell adhesion, migration and invasion compared to the parental Saos2 cells. Conversely, Saos2-l cells grew at a slightly slower rate than that of the parental cells. When injected into nude mice, Saos2-l cells had a greater increase in developing pulmonary metastases compared to the parental Saos2 cells. Further transcriptional profiling analysis revealed that some gene expression were up-regulated or down-regulated in the highly metastatic Saos2-l cells, indicating possible influencing factors of metastasis. Thus, we have established and characterized a highly metastatic human osteosarcoma cell line that should serve as a valuable tool for future investigations on the pathogenesis, metastasis and potential treatments of human osteosarcoma.

Entities:  

Keywords:  Animal model; metastasis; microarray; osteosarcoma

Mesh:

Year:  2014        PMID: 25031706      PMCID: PMC4097260     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  34 in total

Review 1.  Metastasis-suppressor genes: a review and perspective on an emerging field.

Authors:  B A Yoshida; M M Sokoloff; D R Welch; C W Rinker-Schaeffer
Journal:  J Natl Cancer Inst       Date:  2000-11-01       Impact factor: 13.506

2.  Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells.

Authors:  T Ishida; K Penta; M Rezaee; E Yang; J Wohlgemuth; T Quertermous
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

3.  Differential expression of osteogenic factors associated with osteoinductivity of human osteosarcoma cell lines.

Authors:  Yan Yu; Richard I Harris; Jia-Lin Yang; H Clarke Anderson; William R Walsh
Journal:  J Biomed Mater Res A       Date:  2004-07-01       Impact factor: 4.396

4.  Metastasis-associated differences in gene expression in a murine model of osteosarcoma.

Authors:  C Khanna; J Khan; P Nguyen; J Prehn; J Caylor; C Yeung; J Trepel; P Meltzer; L Helman
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

5.  The expression of the urokinase plasminogen activator system in metastatic murine osteosarcoma: an in vivo mouse model.

Authors:  J L Fisher; P S Mackie; M L Howard; H Zhou; P F Choong
Journal:  Clin Cancer Res       Date:  2001-06       Impact factor: 12.531

6.  An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential.

Authors:  C Khanna; J Prehn; C Yeung; J Caylor; M Tsokos; L Helman
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 7.  Adhesion molecules.

Authors:  Amy P N Skubitz
Journal:  Cancer Treat Res       Date:  2002

8.  A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies.

Authors:  S F Jia; L L Worth; E S Kleinerman
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

9.  Tumorigenesis and spontaneous metastasis by luciferase-labeled human xenograft osteosarcoma cells in nude mice.

Authors:  Lin Du; Wen-ting Xu; Qi-ming Fan; Bing Tu; Yang Shen; Wei Yan; Ting-ting Tang; You Wang
Journal:  Chin Med J (Engl)       Date:  2012-11       Impact factor: 2.628

Review 10.  Biology and therapeutic advances for pediatric osteosarcoma.

Authors:  Neyssa Marina; Mark Gebhardt; Lisa Teot; Richard Gorlick
Journal:  Oncologist       Date:  2004
View more
  6 in total

1.  TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances.

Authors:  Xiu-Guo Han; Yan Li; Hui-Min Mo; Kang Li; Du Lin; Chang-Qing Zhao; Jie Zhao; Ting-Ting Tang
Journal:  Tumour Biol       Date:  2016-01-09

2.  Establishment and characterization of a novel human osteosarcoma cell line for spontaneous pulmonary metastasis research in vivo.

Authors:  Pei Yu; Junxiang Wen; Jun Wang; Jing Liang; Yuhui Shen; Weibin Zhang
Journal:  Ann Transl Med       Date:  2019-10

3.  TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 Production.

Authors:  Xiu-Guo Han; Hui-Min Mo; Xu-Qiang Liu; Yan Li; Lin Du; Han Qiao; Qi-Ming Fan; Jie Zhao; Shu-Hong Zhang; Ting-Ting Tang
Journal:  Front Genet       Date:  2018-04-20       Impact factor: 4.599

4.  CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.

Authors:  Lin Du; Xiu-Guo Han; Bing Tu; Min-Qi Wang; Han Qiao; Shu-Hong Zhang; Qi-Ming Fan; Ting-Ting Tang
Journal:  Cell Death Dis       Date:  2018-06-18       Impact factor: 8.469

5.  Tectorigenin inhibits osteosarcoma cell migration through downregulation of matrix metalloproteinases in vitro.

Authors:  Yu Guo; Ya-Hong Chen; Zhi-Hua Cheng; Huo-Niu Ou-Yang; Cong Luo; Zhi-Lin Guo
Journal:  Anticancer Drugs       Date:  2016-07       Impact factor: 2.248

6.  Combination of electroporation delivered metabolic modulators with low-dose chemotherapy in osteosarcoma.

Authors:  Kheshwant S Gill; Philana Fernandes; Brian Bird; Declan M Soden; Patrick F Forde
Journal:  Oncotarget       Date:  2018-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.